Status:
COMPLETED
Web-based Weight Loss Intervention
Lead Sponsor:
23andMe, Inc.
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Excess weight is a major risk factor underlying leading causes of death globally, including cardiovascular disease, type 2 diabetes, and some cancers. Among participants assigned to the same lifestyle...
Detailed Description
23andMe aims to recruit 91,227 adults to participate in a web-based weight loss intervention. Primary aims include: a.) to confirm whether AG/GG individuals at MTIF3 rs1885988 lose more weight on life...
Eligibility Criteria
Inclusion
- US-based men and women in self-reported 'good' or better health
- Consented to participate in research
- BMI 25-40 kg/m2
- Not actively on a weight loss plan
- Willing and able to modify eating and physical activity patterns
- Not under a doctor's care for a serious medical condition
Exclusion
- Are pregnant, lactating, within 6 months postpartum, or planning to become pregnant in the next 6 months
- Have diabetes (type 1 or 2) or are on hypoglycemic medications
- Had a heart attack or stroke within the past year
- Are unable or unwilling to follow a physical activity or diet intervention due to a medical condition or doctor's orders
- Have an eating disorder
- Have severe depression, anxiety, or other psychiatric conditions
Key Trial Info
Start Date :
December 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 16 2019
Estimated Enrollment :
63656 Patients enrolled
Trial Details
Trial ID
NCT03400696
Start Date
December 27 2017
End Date
April 16 2019
Last Update
June 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
23andMe
Mountain View, California, United States, 94041
2
23andMe
Mountain View, California, United States, 94043